Various anticancer drugs such as tamoxifen, octreotide, interferon, and interleukin-2 are used in the treatment of HCC; however, these drugs are not specific for HCC and demonstrate low treatment efficacy [2]. The gene discussed is IL2; the disease is hepatocellular carcinoma.